This randomized controlled trial aims to evaluate the effect of a hybrid breast cancer education program on women's breast cancer awareness, cancer fatalism, and self-compassion levels. The study will include 128 women aged 20-65 who apply to an obstetrics and gynecology outpatient clinic. Participants will be randomly assigned to either an experimental group or a control group. The experimental group will receive a hybrid education model. This model consists of a face-to-face training session using a breast model, followed by four weeks of educational materials, informative messages, and reminders delivered via a mobile application. The control group will receive routine healthcare services without this specific educational intervention. Researchers will measure the participants' levels of self-compassion, breast cancer fatalism, and breast cancer awareness using standardized questionnaires. These measurements will be taken at the beginning of the study (pre-test) and four weeks later (post-test) to determine if the technology-supported hybrid education model is effective in improving early diagnosis awareness and psychosocial outcomes
Being between 20 and 65 years of age
Being female
Agreeing to participate in the study and signing the informed consent form
Having no prior diagnosis of breast cancer
Having a prior diagnosis of breast cancer or active breast pathology
Having any cognitive, mental, or communication barrier that prevents participation in training
Refusing to participate or withdraw consent during the study
Parallel
Hybrid Breast Cancer Education
BehavioralThe experimental group will receive a hybrid breast cancer education model consisting of a face-to-face training session using a breast model, followed by educational materials, informative messages, and reminders delivered via a mobile application over a four-week period
Breast Cancer Awareness Score
Change in participants' breast cancer awareness scores from baseline to 4 weeks post-intervention.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
